Invention Grant
- Patent Title: Compounds that are ERK inhibitors
-
Application No.: US14431462Application Date: 2013-09-26
-
Publication No.: US09233979B2Publication Date: 2016-01-12
- Inventor: Kevin J. Wilson , David J. Witter , Phieng Siliphaivanh , Kathryn Lipford , David Sloman , Danielle Falcone , Brendan O'Boyle , Umar Faruk Mansoor , Jongwon Lim , Joey L. Methot , Christopher Boyce , Lei Chen , Matthew H. Daniels , Salem Fevrier , Xianhai Huang , Ravi Kurukulasuriya , Ling Tong , Wei Zhou , Joseph Kozlowski , Milana M. Maletic , Bidhan A. Shinkre , Jayanth Thiruvellore Thatai , Raman Kumar Bakshi , Ganesh Babu Karunakaran
- Applicant: Merck Sharp & Dohme Corp.
- Applicant Address: US NJ Rahway
- Assignee: Merck Sharp & Dohme Corp.
- Current Assignee: Merck Sharp & Dohme Corp.
- Current Assignee Address: US NJ Rahway
- Agent Richard S. Parr; Laura M. Ginkel
- International Application: PCT/US2013/061878 WO 20130926
- International Announcement: WO2014/052563 WO 20140403
- Main IPC: C07D401/14
- IPC: C07D401/14 ; A61K31/437 ; C07D498/18 ; C07D471/04 ; A61K31/5377 ; A61K31/496 ; C07D471/14 ; A61K31/4375 ; C07D498/14 ; A61K31/553 ; C07D519/00 ; A61K45/06
Abstract:
Disclosed are the ERK inhibitors of formula (1): and the pharmaceutically acceptable salts thereof. Also disclosed are methods of treating cancer using the compounds of formula (1).
Public/Granted literature
- US20150266895A1 NOVEL COMPOUNDS THAT ARE ERK INHIBITORS Public/Granted day:2015-09-24
Information query
